DAORX is designed to support clinical trial cohort matching, real-world evidence acquisition, post-market surveillance, and translational research with consent-enforced, attribution-traceable, audit-grade data licensing. Cohort licenses are intended to be bounded, time-limited, and subject to automatic re-validation against participant consent profiles.
DAORX is designed to provide AI organizations with cryptographic provenance for training data, sample-clearance accounting, and ongoing royalty distribution to data contributors when trained models are commercialized. The system addresses the open question in healthcare AI: where the training data came from, whether consent applied, and how the original contributors are compensated when downstream value is realized.
DAORX is designed to support consent-verified data exchange across payer networks, care coordination programs, and quality reporting workflows. Audit-grade provenance is intended to be built into every access event.
DAORX is designed to operate as a settlement and audit layer beneath existing HIE and TEFCA-aligned interoperability infrastructure, providing consent enforcement and provenance attestation as protocol features rather than as application-level overhead.
DAORX is designed to support federated query architectures with consent-enforced participation, attribution-traceable contribution, and rights administration that compensates participating institutions and individual data contributors.
Institutional engagement with DAORX is intended to follow a structured path: scope discovery and use case alignment, regulatory and compliance review, pilot license design, smart-contract terms negotiation, deployment, and ongoing operation under defined service levels. Each phase is intended to be documented, auditable, and aligned with the institutional customer’s regulatory obligations.
DAORX does not provide medical services, does not replace electronic health record systems, and does not function as a payment processor. DAORX is designed to provide the rights administration and consent enforcement infrastructure that sits beneath those services and lets them operate with cryptographic certainty about consent, provenance, and value distribution.
Healthcare institutions interested in early DAORX engagement — including pharmaceutical research organizations, payer networks, AI development teams, health information exchanges, and academic research consortia — are invited to contact MyRxWallet directly to discuss scope, pilot timing, and integration alignment.